Mimeault M - Search Results

1

Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades.

Mimeault M, Mehta PP, Hauke R, Henichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Growth Factors. 2007 Dec;25(6):400-16. doi: 10.1080/08977190801930935. Growth Factors. 2007. PMID: 18365871

2

Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.

Mimeault M, Batra SK. Mimeault M, et al. Ann Oncol. 2007 Oct;18(10):1605-19. doi: 10.1093/annonc/mdm070. Epub 2007 Mar 12. Ann Oncol. 2007. PMID: 17355951 Free article. Review.

3

New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.

Mimeault M, Batra SK. Mimeault M, et al. Histol Histopathol. 2010 Aug;25(8):1057-73. doi: 10.14670/HH-25.1057. Histol Histopathol. 2010. PMID: 20552555 Free PMC article. Review.

4

Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.

Mimeault M, Johansson SL, Batra SK. Mimeault M, et al. Br J Cancer. 2013 Mar 19;108(5):1079-91. doi: 10.1038/bjc.2012.484. Epub 2013 Feb 28. Br J Cancer. 2013. PMID: 23449353 Free PMC article.

5

New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system.

Mimeault M, Pommery N, Hénichart JP. Mimeault M, et al. Growth Factors. 2003 Mar;21(1):1-14. doi: 10.1080/0897719031000094921. Growth Factors. 2003. PMID: 12795332 Review.

6

Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines.

Mimeault M, Jouy N, Depreux P, Hénichart JP. Mimeault M, et al. Prostate. 2005 Feb 1;62(2):187-99. doi: 10.1002/pros.20138. Prostate. 2005. PMID: 15389789

7

Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.

Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Int J Cancer. 2006 Feb 15;118(4):1022-31. doi: 10.1002/ijc.21440. Int J Cancer. 2006. PMID: 16108016

8

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.

Mimeault M, Batra SK. Mimeault M, et al. Carcinogenesis. 2006 Jan;27(1):1-22. doi: 10.1093/carcin/bgi229. Epub 2005 Sep 29. Carcinogenesis. 2006. PMID: 16195239 Review.

9

Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies.

Mimeault M, Batra SK. Mimeault M, et al. Stem Cells. 2006 Nov;24(11):2319-45. doi: 10.1634/stemcells.2006-0066. Epub 2006 Jun 22. Stem Cells. 2006. PMID: 16794264 Review.

10

Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.

Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Int J Cancer. 2007 Jan 1;120(1):160-9. doi: 10.1002/ijc.22268. Int J Cancer. 2007. PMID: 17013895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters